Xanthogranulomatous cholecystitis (XGC) is a rare, chronic inflammatory disease characterized by accumulation of lipid-laden macrophages (foamy histiocytes/xanthoma cells) in the gallbladder wall. It is frequently confused with gallbladder carcinoma clinically and radiologically (10-30% preoperative malignancy suspicion). Develops on a background of gallstone-related chronic inflammation — stones are present in 85-90% of cases. Progresses through bile infiltration into the wall via Rokitansky-Aschoff sinuses, lipid phagocytosis, granuloma formation, and fibrosis. Adhesions and fistulization to adjacent organs such as liver, duodenum, or colon may develop, strengthening the malignancy mimicry. Incidence: 0.7-13.2% of all cholecystectomies. Slight female predominance in the 60-70 age group. Accurate preoperative diagnosis is difficult and definitive diagnosis is histopathological in most cases.
Age Range
40-80
Peak Age
60
Gender
Female predominant
Prevalence
Rare
The pathogenesis of xanthogranulomatous cholecystitis begins with chronic mucosal damage from gallstones and bile infiltration into the wall. In chronic cholecystitis, mucosal epithelial permeability increases and Rokitansky-Aschoff sinuses (mucosal herniations) enlarge — bile acids, cholesterol, and bilirubin penetrate through these sinuses into wall layers (muscularis propria and subserosa). Extravascular lipid accumulation attracts macrophages which phagocytize lipid and transform into foamy histiocytes (xanthoma cells), then granuloma formation begins. Multinucleated giant cells, lymphocytes, and plasma cells form the inflammatory infiltrate. Concurrent fibrosis and sclerosis develop with marked wall thickening (sometimes 10-20 mm). Yellowish-brown nodular areas (xanthoma accumulation) within the wall macroscopically mimic tumor nodules. In advanced stages, inflammation extends beyond the gallbladder serosa forming adhesions to adjacent liver parenchyma, duodenum, colon, and omentum — this pericholecystic invasion appears on CT as blurring of the hepatic margin, making differentiation from malignancy difficult. The MRI appearance of intramural nodules is based on lipid in xanthoma cells producing fat signal (chemical shift) and fibrous areas showing T2 hypointensity (collagen accumulation causing proton immobility and T2 shortening).
Combination of low-density nodules (xanthoma granulomas) within the thickened gallbladder wall with an uninterrupted mucosal enhancement line. This combination is the strongest radiological criterion for differentiation from carcinoma — in carcinoma the mucosa is disrupted and solid tumor tissue forms wall nodules.
Marked and diffuse gallbladder wall thickening in the portal venous phase (typically 10-20 mm). Small low-density (10-30 HU) nodular or band-like areas within the wall — corresponding to xanthoma granulomas. Surrounding wall tissue enhances while these low-density nodules do not enhance. The mucosal line is usually intact and enhances smoothly — the most valuable CT finding for differentiation from carcinoma (mucosa is disrupted in carcinoma). The outer wall margin may become indistinct from adjacent liver parenchyma.
Report Sentence
Marked diffuse gallbladder wall thickening (__ mm) with low-density nodular areas within the wall; mucosal enhancement integrity is preserved. Findings consistent with xanthogranulomatous cholecystitis; histopathological correlation recommended.
Uninterrupted and smooth enhancement of the gallbladder mucosal line on contrast CT — 'continuous mucosal line' finding. In carcinoma, the mucosa is disrupted by tumor invasion showing focal enhancement defect. In XGC, inflammation concentrates in submucosal and muscular layers but mucosal epithelium is preserved. This finding has the highest predictive value in XGC-carcinoma differentiation (positive predictive value 88-92%). Caution: mucosal ulceration may develop in advanced XGC.
Report Sentence
The gallbladder mucosal enhancement line is continuous and smooth; this finding supports xanthogranulomatous cholecystitis and excludes mucosal disruption expected in carcinoma.
Hypointense nodules and bands within the thickened gallbladder wall on T2-weighted images — corresponding to fibrosis and xanthoma granulomas. These hypointense areas within hyperintense edematous wall tissue create a 'leopard skin' or 'mottled' pattern. Some nodules may be hyperintense on T1 (lipid content). DWI may show mild-moderate diffusion restriction in the thickened wall but not as marked as in carcinoma.
Report Sentence
Hypointense nodular areas within the thickened gallbladder wall on MRI T2; findings consistent with xanthogranulomatous cholecystitis.
Signal drop in some intramural nodules on chemical shift MRI (opposed-phase) — confirming intracellular lipid presence. Nodules with normal/high signal on in-phase show signal drop on opposed-phase (India ink artifact at nodule margins). This finding is a direct indicator of cholesterol accumulation in xanthoma cells and is highly specific for XGC diagnosis. Not all nodules contain lipid — some may be pure fibrosis.
Report Sentence
Signal drop in intramural nodules on opposed-phase chemical shift MRI is identified; intracellular lipid confirmed, strongly supporting xanthogranulomatous cholecystitis.
Marked gallbladder wall thickening (>5 mm, typically >10 mm) with small hypoechoic nodules or bands within the wall on B-mode US. Wall thickening may be diffuse or focal. Gallstones are present in most cases. Inner wall surface may appear smooth and intact. US alone is insufficient for XGC-carcinoma differentiation — should be complemented with CT or MRI.
Report Sentence
Marked gallbladder wall thickening (__ mm) with hypoechoic nodular areas within the wall on US; gallstones present. Complementary CT/MRI evaluation recommended.
Calcified gallstone(s) in the gallbladder lumen on non-contrast CT (85-90% of cases). Fat stranding in the pericholecystic tissue and indistinct margin with adjacent liver parenchyma. These findings in clinical context should suggest XGC.
Report Sentence
Gallstone(s) in the gallbladder lumen with inflammatory changes in pericholecystic fat tissue; indistinct margin with adjacent liver parenchyma.
Criteria
Diffuse thickening of the entire gallbladder wall. Most common type (60-70%).
Distinct Features
Homogeneous thickening throughout the wall with scattered intramural nodules. Differentiation from carcinoma is easier because carcinoma typically shows focal asymmetric thickening.
Criteria
Wall thickening is focally concentrated in one region (usually fundus). In 30-40% of cases.
Distinct Features
Focal mass-like thickening mimics malignancy more closely. Mucosal line evaluation is critical. Frozen section may be needed.
Criteria
Inflammation extends beyond the gallbladder serosa into adjacent liver parenchyma. In 15-25% of cases.
Distinct Features
Pericholecystic hypodense area or abscess formation in the liver. Differentiation from carcinoma liver invasion is very difficult. Mucosal line may remain intact even with hepatic involvement (favoring XGC).
Distinguishing Feature
In gallbladder carcinoma, the mucosal line is DISRUPTED, forms solid enhancing mass, and shows direct liver invasion. In XGC, the mucosal line is INTACT with intramural low-density nodules and diffuse thickening. On MRI, XGC nodules show chemical shift signal drop — carcinoma does not.
Distinguishing Feature
In acute cholecystitis, wall thickening is typically less pronounced (3-8 mm) and homogeneous — intramural low-density nodules are ABSENT. Acute cholecystitis is an acute presentation; XGC has chronic course.
Distinguishing Feature
In adenomyomatosis, intramural Rokitansky-Aschoff sinuses appear as very hyperintense small cystic areas on T2 ('string of pearls' sign). In XGC, intramural nodules are HYPOINTENSE on T2 (fibrosis).
Distinguishing Feature
In chronic cholecystitis, wall thickening is typically homogeneous and symmetric, approximately 3-5 mm. Intramural xanthoma nodules are ABSENT. In XGC, marked thickening (>10 mm) and intramural nodular/heterogeneous appearance differentiate.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
specialist-referralTreatment of XGC is cholecystectomy — needed for symptom control and carcinoma exclusion. Preoperative diagnostic accuracy is 50-70%; 10-30% undergo surgery with malignancy suspicion. Conversion to open surgery is high (30-60%) due to dense adhesions. Radiologist contribution: highlighting intramural nodules, intact mucosal line, and chemical shift signal drop reduces carcinoma suspicion. Prognosis is excellent — XGC is benign and cholecystectomy is curative. Rare: concurrent incidental carcinoma (2-5%) — final pathology should always be evaluated.
XGC is the most important benign mimic of gallbladder carcinoma. Preoperative differentiation is difficult and frozen section may be needed. Cholecystectomy is the treatment. Inflammatory extension into liver parenchyma may complicate surgery.